Microbot Medical Inc (MBOT)
1.01
+0.01
(+1.00%)
USD |
NASDAQ |
May 31, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
Microbot Medical Enterprise Value: 8.194M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 8.194M |
| May 30, 2024 | 8.05M |
| May 29, 2024 | 8.338M |
| May 28, 2024 | 8.338M |
| May 24, 2024 | 8.338M |
| May 23, 2024 | 8.784M |
| May 22, 2024 | 9.202M |
| May 21, 2024 | 7.906M |
| May 20, 2024 | 8.046M |
| May 17, 2024 | 7.188M |
| May 16, 2024 | 7.582M |
| May 15, 2024 | 7.044M |
| May 14, 2024 | 7.316M |
| May 13, 2024 | 7.008M |
| May 10, 2024 | 6.946M |
| May 09, 2024 | 6.898M |
| May 08, 2024 | 6.761M |
| May 07, 2024 | 7.370M |
| May 06, 2024 | 7.618M |
| May 03, 2024 | 7.759M |
| May 02, 2024 | 8.028M |
| May 01, 2024 | 7.474M |
| April 30, 2024 | 6.934M |
| April 29, 2024 | 7.316M |
| April 26, 2024 | 6.322M |
| Date | Value |
|---|---|
| April 25, 2024 | 6.080M |
| April 24, 2024 | 6.480M |
| April 23, 2024 | 6.321M |
| April 22, 2024 | 6.430M |
| April 19, 2024 | 6.106M |
| April 18, 2024 | 6.466M |
| April 17, 2024 | 6.610M |
| April 16, 2024 | 7.313M |
| April 15, 2024 | 8.482M |
| April 12, 2024 | 8.194M |
| April 11, 2024 | 9.202M |
| April 10, 2024 | 9.634M |
| April 09, 2024 | 9.922M |
| April 08, 2024 | 10.50M |
| April 05, 2024 | 11.36M |
| April 04, 2024 | 11.79M |
| April 03, 2024 | 11.79M |
| April 02, 2024 | 11.22M |
| April 01, 2024 | 12.80M |
| March 28, 2024 | 11.33M |
| March 27, 2024 | 10.17M |
| March 26, 2024 | 9.814M |
| March 25, 2024 | 10.46M |
| March 22, 2024 | 10.75M |
| March 21, 2024 | 10.17M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.4684M
Minimum
Mar 16 2020
65.08M
Maximum
Dec 24 2019
22.06M
Average
22.34M
Median
May 07 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Retractable Technologies Inc | -13.51M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Catheter Precision Inc | 2.370M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.371M |
| Total Expenses (Quarterly) | 2.384M |
| EPS Diluted (Quarterly) | -0.17 |
| Earnings Yield | -88.12% |
| Normalized Earnings Yield | -63650.69 |